AAAAAA

   
Results: 1-11 |
Results: 11
Effect of timolol 0.5% gel and solution on pulmonary function in older glaucoma patients
Authors: Stewart, WC Day, DG Holmes, KT Stewart, JA
Citation: Wc. Stewart et al., Effect of timolol 0.5% gel and solution on pulmonary function in older glaucoma patients, J GLAUCOMA, 10(3), 2001, pp. 227-232
Twenty-four hour intraocular pressure reduction with latanoprost compared with pilocarpine third-line therapy in exfoliation glaucoma
Authors: Konstas, AGP Lake, S Maltezos, AC Holmes, KT Stewart, WC
Citation: Agp. Konstas et al., Twenty-four hour intraocular pressure reduction with latanoprost compared with pilocarpine third-line therapy in exfoliation glaucoma, EYE, 15, 2001, pp. 59-62
Brimonidine 0.2% given two or three times daily versus timolol maleate 0.5% in primary open-angle glaucoma
Authors: Konstas, AGP Stewart, WC Topouzis, F Tersis, I Holmes, KT Stangos, NT
Citation: Agp. Konstas et al., Brimonidine 0.2% given two or three times daily versus timolol maleate 0.5% in primary open-angle glaucoma, AM J OPHTH, 131(6), 2001, pp. 729-733
Washout periods for brimonidine 0.2% and latanoprost 0.005%
Authors: Stewart, WC Holmes, KT Johnson, MA
Citation: Wc. Stewart et al., Washout periods for brimonidine 0.2% and latanoprost 0.005%, AM J OPHTH, 131(6), 2001, pp. 798-799
Additive efficacy of unoprostone isopropyl 0.12% (Rescula) to latanoprost 0.005%
Authors: Stewart, WC Sharpe, ED Stewart, JA Holmes, KT Latham, KE
Citation: Wc. Stewart et al., Additive efficacy of unoprostone isopropyl 0.12% (Rescula) to latanoprost 0.005%, AM J OPHTH, 131(3), 2001, pp. 339-344
Therapeutic success of latanoprost 0.005% compared to brimonidine 0.2% in patients with open-angle glaucoma or ocular hypertension
Authors: Stewart, WC Day, DG Stewart, JA Holmes, KT Leech, JN Rowan, CT Schwartz, GF
Citation: Wc. Stewart et al., Therapeutic success of latanoprost 0.005% compared to brimonidine 0.2% in patients with open-angle glaucoma or ocular hypertension, J OCUL PH T, 16(6), 2000, pp. 557-564
Comparison of the efficacy and safety of latanoprost 0.005% compared to brimonidine 0.2% or dorzolamide 2% when added to a topical beta-adrenergic blocker in patients with primary open-angle glaucoma or ocular hypertension
Authors: Stewart, WC Sharpe, ED Day, DG Kolker, AE Konstas, AGP Lee, WH Rieser, JC Chopra, H Holmes, KT
Citation: Wc. Stewart et al., Comparison of the efficacy and safety of latanoprost 0.005% compared to brimonidine 0.2% or dorzolamide 2% when added to a topical beta-adrenergic blocker in patients with primary open-angle glaucoma or ocular hypertension, J OCUL PH T, 16(3), 2000, pp. 251-259
Differences in ocular surface irritation between timolol hemihydrate and timolol maleate
Authors: Stewart, WC Stewart, JA Holmes, KT Leech, JN
Citation: Wc. Stewart et al., Differences in ocular surface irritation between timolol hemihydrate and timolol maleate, AM J OPHTH, 130(6), 2000, pp. 712-716
Factors associated with long-term progression or stability in primary open-angle glaucoma
Authors: Stewart, WC Kolker, AE Sharpe, ED Day, DG Holmes, KT Leech, JN Johnson, M Cantrell, JB
Citation: Wc. Stewart et al., Factors associated with long-term progression or stability in primary open-angle glaucoma, AM J OPHTH, 130(3), 2000, pp. 274-279
Brimonidine 0.2% versus dorzolamide 2% each given three times daily to reduce intraocular pressure
Authors: Stewart, WC Sharpe, ED Harbin, TS Pastor, SA Day, DG Holmes, KT Stewart, JA
Citation: Wc. Stewart et al., Brimonidine 0.2% versus dorzolamide 2% each given three times daily to reduce intraocular pressure, AM J OPHTH, 129(6), 2000, pp. 723-727
Efficacy and safety of timolol solution once daily vs timolol gel added tolatanoprost
Authors: Stewart, WC Day, DG Sharpe, ED Dubiner, HB Holmes, KT Stewart, JA
Citation: Wc. Stewart et al., Efficacy and safety of timolol solution once daily vs timolol gel added tolatanoprost, AM J OPHTH, 128(6), 1999, pp. 692-696
Risultati: 1-11 |